2026-04-13 – Press Releases – www.prnewswire.com
The DOORwaY90 study met its prespecified co-primary endpoints, achieving a best overall response rate (ORR) of 99% WOBURN, Mass., April 13, 2026 /PRNewswire/ — Sirtex Medical (“Sirtex”), a leading manufacturer of interventional oncology and embolization solutions, today announced…
